Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Evgen Pharma ( (GB:TCF) ) is now available.
Theracryf PLC, a UK-based company, has announced a change in its major holdings, as Oberon Investments Limited has acquired or disposed of voting rights, crossing a significant threshold on March 11, 2025. This notification, completed on March 21, 2025, indicates Oberon now holds 3.779% of the voting rights, totaling 80,475,000 shares, which may impact the company’s governance and stakeholder influence.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 3,792,212
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £4.79M
Learn more about TCF stock on TipRanks’ Stock Analysis page.